Ischemia-Modified Albumin: A Potential New Marker of Oxidative Stress in Dermatological Diseases
May 2022
in “
Medicina-lithuania
”
Studysummary This review discusses ischemia-modified albumin as a potential new marker of oxidative stress in dermatological diseases but reports no new clinical findings.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on mdpi.com →